Pharmafile Logo
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • - PMLiVE
  • Communiqué 53 Cover Image

VJOncology

- PMLiVE

Lilly psoriasis drug beats J&J’s Tremfya in head-to-head trial

Shifting expectations in psoriasis outcomes

- PMLiVE

Signant Health’s vice president included in PharmaVOICE 100

David Daniel was nominated by peers

- PMLiVE

Boehringer Ingelheim forms ‘virtual research’ alliance with MD Anderson

Will focus on developing cancer therapies

- PMLiVE

Vertex faces rejection of its CF medicines in Scotland

Another rejection over cost-effectiveness

- PMLiVE

GSK hires Merck KGaA exec to lead US pharma business

Martinez-Davis will help strengthen company’s oncology focus

- PMLiVE

Humana lawsuit targets Mallinckrodt’s ‘billion-dollar golden goose’

Latest twist in long story of Acthar

AI is transforming pharma R&D – now it can transform pharma marketing

by Chris Finch

- PMLiVE

Novo Nordisk boosted by new type 2 diabetes launches

Rapid uptake of newcomer Ozempic aids growth

- PMLiVE

Boris Johnson announces fast-track immigration plans for top scientists

Industry welcomes news but doubt over no-deal Brexit remains

- PMLiVE

Amgen wins Enbrel patent case, knocking back Sandoz’s biosimilar plan

Shares up 6% following court ruling

Novartis day

Senators attack Novartis over ‘unconscionable’ handling of Zolgensma data

Ask FDA to hold the company ‘accountable’

How is the NHS Long-term Plan being put into action?

Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published

Wilmington Healthcare

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links